RxDoctor Payments Data

Wayne Woodbury, MD

Pain Medicine · Jonesborough, TNNPI 1770572893

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $7,630 of the $9,597 with a category attached, or 79.5%. 22 manufacturers reported payments, led by Nevro Corp. at 35.4% of the total. Reporting peaked in 2019 at $3,682 and has fallen 68.1% since, to $1,176 in 2025.

$9,597in general payments, 2019–2025

Across 415 payments — averaging $23.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Nevro Corp.$3K
  • Medtronic$3K
  • Collegium Pharmaceutical, Inc.$1K
  • Tersera Therapeutics LLC$516
  • Scilex Pharmaceuticals Inc.$205
  • Boston Scientific$139
  • plus $790 from 16 others

What the payments were for

  • Travel & lodging$1,96720%
  • Food & beverage$7,63080%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,597 in reported general payments places this provider in the 75th percentile of 112 pain medicine providers in Tennessee.

See all pain medicine providers in Tennessee

Medicare billing

Part B allowed, 2024
$175,336
Medicare patients
319
Services billed
7,029

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone Hcl22$445
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen11$258
Gabapentin31$249
Pregabalin16$173
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen11$159
Tizanidine Hcl12$57

Paid to pharmacies, not to this prescriber.

Other pain medicine in Jonesborough

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →